Triamcinolone acetonide 40 mg

DRUG4 trials

Sponsors

Novartis Pharmaceuticals, Swedish Orphan Biovitrum

Conditions

Acute GoutAcute Gouty ArthritisAcute Gouty Arthritis Flares

Phase 2

A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis

CompletedNCT03002974

Swedish Orphan BiovitrumAcute Gouty Arthritis

Start: 2016-12-31End: 2019-08-31Updated: 2020-07-15

Phase 3

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

CompletedNCT01029652

Novartis PharmaceuticalsAcute Gout

Start: 2009-12-31End: 2010-10-31Updated: 2014-01-30

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.

CompletedNCT01080131

Novartis PharmaceuticalsAcute Gout

Start: 2010-03-31End: 2011-10-31Updated: 2014-01-30

β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)

CompletedNCT01470989

Novartis PharmaceuticalsAcute Gouty Arthritis Flares

Start: 2011-11-30End: 2013-05-31Updated: 2021-07-09